人民财讯1月21日电，上海电气（601727）1月21日公告，预计2025年度归属于母公司所有者的净利润为 11亿元至13.2亿元，同比增加约47%至76%。报告期内，公司持续聚焦主责主业、深化经营，核心业务 保持稳健增长，营业收入与利润总额均实现同比提升。 ...

人民财讯1月21日电，天孚通信（300394）1月21日发布业绩预告，预计2025年归母净利18.81亿元—21.5 亿元，同比增长40%—60%。报告期内，得益于人工智能行业加速发展与全球数据中心建设，带动了高 速光器件产品需求的持续稳定增长，叠加公司智能制造持续降本增效，共同促进了公司有源和无源产品 线营收增长。另一方面，受汇兑损失影响，财务费用同比上升，对本期业绩增长产生一定负向影响。 ...

人民财讯1月21日电，广东省人民政府办公厅印发《广东省人工智能赋能交通运输高质量发展若干政策 措施》，其中提到，升级智慧港口运营能力。探索应用基于AI视觉识别与运筹优化的泊位和堆场智能 调度方法，实现堆场资源、内外集卡运输任务动态分配与路径优化，提升船舶靠泊与装卸作业效能。探 索区块链技术在港口的应用，推动提单、舱单等核心单证数字化并上链，实现单证流程自动化和物流全 程可视化，提升运输效率和安全性。鼓励构建智能集疏运调度服务平台，推动内外贸、跨方式、跨环 节、多节点港口集疏运智能调度建设。推动港口企业提升安全管理智能化水平，精准识别安全隐患，对 关键作业场所实现全时段动态监测和风险实时预警，降低安全风险。 ...

Core Viewpoint - The Guangdong Provincial Government has issued policies to enhance the quality of transportation development through artificial intelligence, focusing on smart road construction and operations [1] Group 1: Smart Road Construction - The initiative promotes the construction of smart roads by integrating artificial intelligence with domestic BIM technology, creating a new model of "digital surveying + digital design + intelligent construction" [1] - There is an emphasis on the research and application of intelligent construction technologies and building robots, utilizing smart perception and IoT for real-time monitoring and efficient collaboration during construction [1] - The development of "smart factories" and "smart construction sites" is a key focus area [1] Group 2: Smart Maintenance - The policies advocate for the application of unmanned machine inspections and data fusion analysis to conduct intelligent analysis and monitoring of infrastructure issues [1] - There will be a focus on intelligent matching of improvement measures and continuous monitoring to evaluate governance effectiveness, forming a closed-loop management system [1] Group 3: Smart Operations - The integration of multi-source perception data aims to build models for assessing road network operational status, video intelligent analysis, and traffic situation simulation [1] - The initiative seeks to enhance the ability to analyze the causes of traffic congestion, manage emergency resource allocation, and improve collaborative control [1] - There is a plan to develop real-time perception and judgment models to dynamically open emergency lanes under safe conditions to alleviate congestion [1] Group 4: Smart Services - The policies promote the intelligent upgrade of toll stations and service areas, exploring intelligent judgment and multi-method guidance to achieve resource sharing between service facilities along highways [1] - The integration of travel service data resources aims to continuously upgrade and improve the "Yue Tongxing" public travel service operation system [1]

Core Viewpoint - Jincheng Pharmaceutical (300233) announced the approval of a supplemental application for injectable Cefuroxime Sodium by the National Medical Products Administration, indicating a significant development in its product portfolio [1] Group 1: Product Approval - The approved drug, injectable Cefuroxime Sodium, is primarily used for treating infections caused by bacteria sensitive to Cefuroxime, including respiratory and ENT infections, urinary tract infections, skin and soft tissue infections, sepsis, meningitis, and bone and joint infections [1]

人民财讯1月21日电，毅昌科技（002420）1月21日发布业绩预告，预计2025年归母净利1.5亿元—2.25亿 元，同比增长58%—138%。报告期内，公司通过摆脱单一传统业务结构，向高附加值、高成长性的汽 车与新能源行业加速布局，实现业务升级。基于公司的发展战略和规划，进一步优化公司的资源配置， 子公司江苏毅昌科技有限公司、江苏设计谷科技有限公司转让其持有的土地及相关项目资产，资产处置 收益约1.4亿元计入非经常性损益。 ...

人民财讯1月21日电，翱捷科技(688220)1月21日公告，公司预计2025年实现归属于母公司所有者的净利 润为亏损3.99亿元左右，较2024年亏损金额减少2.94亿元左右，报告期内，随着公司产品的不断丰富， 产品覆盖的应用场景进一步拓展，芯片销量较上年同期实现大幅增长，带动整体营业收入实现持续增 长，收入增长幅度为12.73%左右；公司在研发方面继续保持大额投入，预计2025年研发投入13.02亿元 左右，较上年同期增长4.89%左右。 ...

人民财讯1月21日电，广东省人民政府办公厅印发《广东省人工智能赋能交通运输高质量发展若干政策 措施》，其中提到，加强交通运输数据供给。以交通行业数字底座建设为引领，深化数据汇聚，强化数 据治理，提升行业数据质量，扩大优质数据供给。构建交通行业数据资源目录体系，推动公路、铁路、 港航、运输等全要素数据标准化、规范化建设。开展公共数据授权运营试点，探索交通数据要素产品化 开发，加快构建智慧路网、智慧养护、数字港航、智慧出行等应用场景高质量数据集，为人工智能能力 提升和应用场景落地提供关键支撑。 ...

人民财讯1月21日电，企查查APP显示，近日，泊壤(安吉)农业旅游有限公司成立，法定代表人为易萱， 注册资本500万人民币，经营范围含旅游业务、组织文化艺术交流活动、商标代理等，由小红书旗下璞 真乡里(上海)旅游文化有限公司全资持股。 ...

Core Viewpoint - The launch of the world's first "Hepatitis B Cure AI Assistant" by Yidu Technology in collaboration with Chongqing Medical University Second Affiliated Hospital aims to provide a comprehensive closed-loop service for Hepatitis B management, addressing issues such as fragmented information and inefficient clinical research recruitment [1][2]. Group 1: AI Assistant Features - The AI assistant is built on a medical domain-specific large model and offers a one-stop service covering screening, diagnosis, treatment, follow-up, and research [1]. - It operates on a smart management system that integrates clinical pathways and utilizes retrieval-augmented generation (RAG) technology to create a digital support system throughout the disease management process [1][2]. - The assistant acts as a "personal health manager," enabling continuous intelligent services for patients, including follow-ups, personalized education, health consultations, and appointment reminders [1]. Group 2: Clinical Collaboration and Data Integration - The AI assistant enhances clinical collaboration by covering the entire process from high-risk population screening to long-term follow-up and rehabilitation guidance, while also bridging the gap between research and clinical data [2]. - The collaboration between Yidu Technology and Chongqing Medical University has led to the establishment of a high-quality "Hepatitis B Specialty Database," which supports the AI assistant's capabilities [2]. - The assistant's effectiveness has been validated in clinical settings, demonstrating its ability to provide personalized risk assessments and decision support based on complex medical logic [2]. Group 3: Future Developments - The AI assistant is currently undergoing testing on both mobile and computer platforms, with plans for patients to access pre-consultation services and expert recommendations through a user-friendly interface [3]. - Yidu Technology plans to explore innovative services such as specialized large models and digital avatars for doctors, expanding the boundaries of intelligent management in the field of liver disease [3].